Alexander L. Johnson - 01 Feb 2023 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role: Chief Business Officer
Signature: /s/ Reginald Seeto, as attorney-in-fact for Alexander L. Johnson
Issuer symbol: CDNA
Transactions as of: 01 Feb 2023
Net transactions value: -$59,203
Form type: 4
Filing time: 03 Feb 2023, 20:46:26 UTC
Previous filing: 31 Jan 2023
Next filing: 07 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDNA	Common Stock	Award	$0	+85,100	+76%	$0.000000	197,450	01 Feb 2023	Direct	F1
transaction	CDNA	Common Stock	Award	$0	+3,200	+1.6%	$0.000000	200,650	01 Feb 2023	Direct	F2
transaction	CDNA	Common Stock	Tax liability	$9,678	-618	-0.31%	$15.66	200,032	01 Feb 2023	Direct	F3
transaction	CDNA	Common Stock	Tax liability	$35,731	-2,029	-1%	$17.61	198,003	02 Feb 2023	Direct	F4
transaction	CDNA	Common Stock	Tax liability	$6,897	-417	-0.21%	$16.54	197,586	03 Feb 2023	Direct	F4
transaction	CDNA	Common Stock	Tax liability	$6,897	-417	-0.21%	$16.54	197,169	03 Feb 2023	Direct	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDNA	Stock Option (right to buy)	Award	$0	+44,100		$0.000000	44,100	01 Feb 2023	Common Stock	44,100	$15.66	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities are represented by restricted stock units, 1/4th of which shall vest on February 1, 2024 and 1/4th of which shall vest on each anniversary thereafter.
F2	The reported securities were subject to a performance restricted stock unit award that was initially granted on February 3, 2021 for a two-year performance period over calendar years 2021 and 2022, which performance was assessed and finalized effective February 1, 2023. 50.00% of the reported securities vested on February 1, 2023 and 50% of the reported securities will vest on December 31, 2023, subject to the Reporting Person's continued service with the Issuer.
F3	These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of performance restricted stock units.
F4	These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
F5	1/4th of the shares subject to the option shall vest on February 1, 2024 and 1/48th of the shares subject to the option shall vest monthly thereafter.